Literature DB >> 12475252

E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).

Linda Troeberg1, Mitsuo Tanaka, Robin Wait, Yeunian E Shi, Keith Brew, Hideaki Nagase.   

Abstract

The inhibitory properties of TIMP-4 for matrix metalloproteinases (MMPs) were compared to those of TIMP-1 and TIMP-2. Full-length human TIMP-4 was expressed in E. coli, folded from inclusion bodies, and the active component was purified by MMP-1 affinity chromatography. Progress curve analysis of MMP inhibition by TIMP-4 indicated that association rate constants (k(on)) and inhibition constants (K(i)) were similar to those for other TIMPs ( approximately 10(5) M(-)(1) s(-)(1) and 10(-)(9)-10(-)(12) M, respectively). Dissociation rate constants (k(off)) for MMP-1 and MMP-3 determined using alpha(2)-macroglobulin to capture MMP dissociating from MMP-TIMP complexes were in good agreement with values deduced from progress curves ( approximately 10(-)(4) s(-)(1)). K(i) and k(on) for the interactions of TIMP-1, -2, and -4 with MMP-1 and -3 were shown to be pH dependent. TIMP-4 retained higher reactivity with MMPs at more acidic conditions than either TIMP-1 or TIMP-2. Molecular interactions of TIMPs and MMPs investigated by IAsys biosensor analysis highlighted different modes of interaction between proMMP-2-TIMP-2 (or TIMP-4) and active MMP-2-TIMP-2 (or TIMP-4) complexes. The observation that both active MMP-2 and inactive MMP-2 (with the active site blocked either by the propeptide or a hydroxamate inhibitor) have essentially identical affinities for TIMP-2 suggests that there are two TIMP binding sites on the hemopexin domain of MMP-2: one with high affinity that is involved in proMMP-2 or hydroxamate-inhibited MMP-2; and the other with low affinity involved in formation of the complex of active MMP-2 and TIMP-2. Similar models of interaction may apply to TIMP-4. The latter low-affinity site functions in conjunction with the active site of MMP-2 to generate a tight enzyme-inhibitor complex.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12475252     DOI: 10.1021/bi026454l

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

1.  Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).

Authors:  Marie Kveiborg; Jonas Jacobsen; Meng-Huee Lee; Hideaki Nagase; Ulla M Wewer; Gillian Murphy
Journal:  Biochem J       Date:  2010-08-15       Impact factor: 3.857

2.  Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function.

Authors:  Charlotte Selvais; Ludovic D'Auria; Donatienne Tyteca; Gwenn Perrot; Pascale Lemoine; Linda Troeberg; Stéphane Dedieu; Agnès Noël; Hideaki Nagase; Patrick Henriet; Pierre J Courtoy; Etienne Marbaix; Hervé Emonard
Journal:  FASEB J       Date:  2011-04-25       Impact factor: 5.191

3.  Evidence for restricted reactivity of ADAMDEC1 with protein substrates and endogenous inhibitors.

Authors:  Jacob Lund; Linda Troeberg; Henrik Kjeldal; Ole H Olsen; Hideaki Nagase; Esben S Sørensen; Henning R Stennicke; Helle H Petersen; Michael T Overgaard
Journal:  J Biol Chem       Date:  2015-01-06       Impact factor: 5.157

4.  Slow, reversible, coupled folding and binding of the spectrin tetramerization domain.

Authors:  S L Shammas; J M Rogers; S A Hill; J Clarke
Journal:  Biophys J       Date:  2012-11-20       Impact factor: 4.033

5.  Translocating a High-Affinity Designer TIMP-1 to the Cell Membrane for Total Renal Carcinoma Inhibition: Putting the Prion Protein to Good Use.

Authors:  Bingjie Jiang; Yuewei Xu; Yihe Zhang; Meng Huee Lee
Journal:  Mol Cell Biol       Date:  2019-08-27       Impact factor: 4.272

6.  Long-term expression of tissue-inhibitor of matrix metalloproteinase-1 in the murine central nervous system does not alter the morphological and behavioral phenotype but alleviates the course of experimental allergic encephalomyelitis.

Authors:  Gioia E M Althoff; David P Wolfer; Nina Timmesfeld; Benoit Kanzler; Heinrich Schrewe; Axel Pagenstecher
Journal:  Am J Pathol       Date:  2010-06-17       Impact factor: 4.307

7.  Inactivation of N-TIMP-1 by N-terminal acetylation when expressed in bacteria.

Authors:  Steven R Van Doren; Shuo Wei; Guanghua Gao; Beverly B DaGue; Mark O Palmier; Harinath Bahudhanapati; Keith Brew
Journal:  Biopolymers       Date:  2008-11       Impact factor: 2.505

8.  The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3.

Authors:  Linda Troeberg; Kazunari Fushimi; Simone D Scilabra; Hiroyuki Nakamura; Vincent Dive; Ida B Thøgersen; Jan J Enghild; Hideaki Nagase
Journal:  Matrix Biol       Date:  2009-07-28       Impact factor: 11.583

9.  SIRT1 redresses the imbalance of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-9 in the development of mouse emphysema and human COPD.

Authors:  Hongwei Yao; Jae-woong Hwang; Isaac K Sundar; Alan E Friedman; Michael W McBurney; Leonard Guarente; Wei Gu; Vuokko L Kinnula; Irfan Rahman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-09-13       Impact factor: 5.464

10.  Differential expression of extracellular matrix components in the Fallopian tubes throughout the menstrual cycle.

Authors:  Patricia S Diaz; Paula A Solar; Natalia E Juica; Pedro A Orihuela; Hugo Cardenas; Myron Christodoulides; Renato Vargas; Luis A Velasquez
Journal:  Reprod Biol Endocrinol       Date:  2012-08-16       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.